Overactive Bladder Syndrome
Conditions
Keywords
Overactive Bladder, Electric Stimulation, Physical Therapy Modalities
Brief summary
To evaluate the efficacy of combined transvaginal electrical stimulation (ES) and transcutaneous tibial nerve electrical stimulation (TTNS) in the treatment of female overactive bladder syndrome (OAB).
Detailed description
This is a clinical trial, blind and randomized study with 86 women with OAB or Mixed Urinary Incontinence with prevalence in the OAB symptoms, who were randomly and allocated into 2 equal groups. Group 1 underwent transcutaneous tibial nerve electrical stimulation (TTNS),for 30 minutes using 10Hz for frequency and 200µs for pulse. Group 2 received a combined of Vaginal electrical stimulation (ES) using a transvaginal probe applied ,for 20 minutes using 10Hz for frequency and 1ms for pulse and tibial nerve electrical stimulation, 30 minutes at the same parameters used in Group1. Both groups were treated once a week for 12 sessions. All patients were evaluated before and after treatment by a voiding diary, King´s Health questionnaire, avaliation of pelvic floor muscle function, overactive bladder questionnaire (OABV-8).The analyzed variables included day and night time frequency, urgency and urge incontinence. The sample calculation was based on the difference waited between 2 groups regarding the frequency improvment.
Interventions
Transcutaneous tibial electric stimulation
Transvaginal electric stimulation
Sponsors
Study design
Masking description
All the questionnaires (OABV-8, King´s Health, Anamnesis), Function Avaliation of Pelvic Floor Muscles, before and after treatment will be conduced by other person who is not the responsable for the research.
Intervention model description
Group 1: will be treated receiving Transcutaneous Tibial Electric Stimulation Group 2: will be treated receiving TTNS and Transvaginal Electric Stimulation
Eligibility
Inclusion criteria
* Women diagnosed with Overactive Bladder Syndrom no neurogenic or Mixed Incontinence Urinary with overactive bladder´s predominance symptoms more than 6 months. * Over 18 years old. * Normal cognitive level to understand the orientations during the treatment.
Exclusion criteria
* Stress Urinary Incontinence * Drugs treatment for overactive bladder * Pregnant women * Neurologic diseases * Urinary infecction * Cystocele, rectocele and uterine prolapse * Infectious contagious diseases * Metal implants on the hip or lower members * Cardiac pacemaker * Bladder tumor * Vaginal infecction
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Decreasing the numbers of urinary frequency during day and night | 1 month | We expect that patiens will decrease the void´s number during day (under 8), and during night, recovering theirs life´s quality. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Improvement of miccional urgency and urinary urgency incontinence | 2 months | We expect that patients will get better decreasing symptoms of urinary urgency and urinary incontinence urgency consequently. |
Countries
Brazil